Research article
Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study
-
* Corresponding author: John Souglakos johnsougl@gmail.com
BMC Cancer 2007, 7:91 doi:10.1186/1471-2407-7-91
No comments have yet been made on this article.